Cardiovascular Systems, Inc. (CSII) Financial Statements (2025 and earlier)

Company Profile

Business Address 1225 OLD HWY 8 NW
ST. PAUL, MN 55112
State of Incorp. DE
Fiscal Year End June 30
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments207,038232,154122,672116,804108,61661,322
Cash and cash equivalent71,070185,46374,237116,260107,91260,638
Short-term investments135,96846,69148,435544704684
Receivables40,03325,21236,01531,22528,47223,128
Inventory, net of allowances, customer advances and progress billings32,31327,70618,05816,60516,89717,440
Inventory32,31327,70618,05816,60516,89717,440
Other undisclosed current assets5,2852,6173,3302,9775,0742,992
Total current assets:284,669287,689180,075167,611159,059104,882
Noncurrent Assets
Property, plant and equipment28,89427,81027,32427,74429,69632,471
Long-term investments and receivables      
Long-term investments      
Intangible assets, net (including goodwill)15,37616,6065,1055,2315,0565,013
Intangible assets, net (excluding goodwill)15,37616,6065,1055,2315,0565,013
Other noncurrent assets23,6287,4146,0732,76612940
Other undisclosed noncurrent assets      
Total noncurrent assets:67,89851,83038,50235,74134,88137,524
TOTAL ASSETS:352,567339,519218,577203,352193,940142,406
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities52,25042,63940,58136,21740,97235,499
Employee-related liabilities      
Accounts payable14,06111,53911,19410,44110,7368,506
Accrued liabilities38,18931,10029,38725,77630,23626,993
Deferred revenue2,4001,867
Deferred revenue and credits1,243  
Other undisclosed current liabilities  1,764   
Total current liabilities:54,65044,50642,34537,46040,97235,499
Noncurrent Liabilities
Long-term debt and lease obligation:      
Liabilities, other than long-term debt6,3635,40377510,35813,4796,010
Deferred revenue and credits8,94610,000 
Deferred revenue 2,1944,707
Other liabilities4,1696967751,4123,4796,010
Operating lease, liability  
Other undisclosed noncurrent liabilities20,59620,81827,51321,06421,100 
Total noncurrent liabilities:26,95926,22128,28831,42234,5796,010
Total liabilities:81,60970,72770,63368,88275,55141,509
Equity
Equity, attributable to parent270,958268,792147,944134,470118,389100,897
Common stock393934333333
Additional paid in capital652,288631,559477,368461,927447,559428,235
Accumulated other comprehensive income (loss)112697810110040
Accumulated deficit(381,380)(363,075)(329,536)(327,591)(329,303)(327,411)
Total equity:270,958268,792147,944134,470118,389100,897
TOTAL LIABILITIES AND EQUITY:352,567339,519218,577203,352193,940142,406

Income Statement (P&L) ($ in thousands)

6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Revenues258,973236,545248,017217,043204,906178,184
Revenue, net217,043204,906178,184
Cost of revenue(61,131)(48,759)(47,680)(39,484)(39,441)(35,421)
Cost of product and service sold(2,997)  (39,484)(39,441)(35,421)
Gross profit:197,842187,786200,337177,559165,465142,763
Operating expenses(209,775)(214,558)(201,162)(175,325)(167,007)(198,840)
Operating income (loss):(11,933)(26,772)(825)2,234(1,542)(56,077)
Nonoperating income (expense)(1,236)(233)760(390)(164)53
Other nonoperating income (expense)     (47)53
Interest and debt expense(1,735)(1,973)(1,684)(1,717)(500) 
Income (loss) from continuing operations before equity method investments, income taxes:(14,904)(28,978)(1,749)127(2,206)(56,024)
Other undisclosed income from continuing operations before income taxes1,7351,9731,6841,717500 
Income (loss) from continuing operations before income taxes:(13,169)(27,005)(65)1,844(1,706)(56,024)
Income tax expense(252)(231)(190)(132)(86) 
Income (loss) from continuing operations:(13,421)(27,236)(255)1,712(1,792)(56,024)
Income (loss) before gain (loss) on sale of properties:(13,421)(27,236)(255)1,712(1,792)(56,024)
Net income (loss) attributable to parent:(13,421)(27,236)(255)1,712(1,792)(56,024)
Undistributed earnings (loss) allocated to participating securities, basic    19
Net income (loss) available to common stockholders, diluted:(13,421)(27,236)(255)1,731(1,792)(56,024)

Comprehensive Income ($ in thousands)

6/30/2022
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net income (loss):(13,421)(27,236)(255)1,712(1,792)(56,024)
Other comprehensive income  19178356620
Comprehensive income (loss):(13,421)(27,045)(177)1,747(1,726)(56,004)
Other undisclosed comprehensive loss, net of tax, attributable to parent(258)  (34)(6)(70)
Comprehensive income (loss), net of tax, attributable to parent:(13,679)(27,045)(177)1,713(1,732)(56,074)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: